Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Quality Marches On: The Final Hospital Value-Based Purchasing Rule And The New Partnership For Patients Program

Publications

May 20, 2011

The Centers for Medicare & Medicaid Services ("CMS") recently issued the final value-based purchasing rule for hospital inpatient services (the "Final Rule").1 With a few exceptions, the Final Rule is essentially unchanged from the original proposed version of the rule that we discussed in a previous issue of Health Reform IMPACT.2 As our readers may recall, the value-based purchasing program, which ties part of a hospital’s Medicare reimbursement to achieving certain quality standards, is a mandate of the Patient Protection and Affordable Care Act ("PPACA").3

Under the Final Rule, CMS will distribute an estimated $850 million to Medicare participating hospitals based on their overall performance on a set of quality measures that have been linked to improved clinical processes of care and patient satisfaction. A hospital’s "score", which determines the size of the hospital’s incentive payment, will be weighted as follows for the first year of program: 30 percent will be based on patient experience scores using the Hospital Consumer Assessment of Healthcare Providers and Systems survey ("HCAHPS"); and 70 percent will be based on 12 clinical process-of-care measures. The proposed rule had included 17 process-of-care measures rather than 12, but five were removed from the final rule because CMS believed the majority of hospitals had already "topped out", or reached a high level of performance, on those metrics. Some of the measures are intended to assess, among other things, whether hospitals:

  • Ensure that patients who may have had a heart attack receive care within 90 minutes;
  • Provide care within a 24-hour window to surgery patients to prevent blood clots; and
  • Communicate discharge instructions to heart failure patients.

Hospitals’ scores may be based on their levels of achievement of quality measures relative to other hospitals, or their levels of improvement in comparison to their own prior data.4 To determine a baseline for each hospital for the first year of the program, CMS will analyze previously reported hospital data from July 1, 2009 through March 31, 2010. CMS will compare this baseline against data that will be collected during an initial performance period running from July 1, 2011 to March 31, 2012. On the basis of this data, CMS will begin making incentive payments to hospitals for discharges occurring on or after October 1, 2012 (i.e. the beginning of fiscal year 2013).

In the future, CMS plans to add measures that focus on improved patient outcomes and prevention of hospital-acquired conditions. Measures that have reached very high compliance scores will likely be replaced. Beginning in 2014, CMS will introduce three mortality outcome measures, eight hospital-acquired condition measures, and two Agency for Healthcare Research and Quality ("AHRQ") composite measures. In one of the few changes from the proposed rule, CMS decided not to implement a plan to adopt and retire measures using a sub-regulatory process that would forgo notice and comment.

To make the value-based program budget-neutral, CMS will implement an across-the-board 1 percent reduction in hospitals’ base operating diagnosis-related group ("DRG") payments, starting October 1, 2012, and will use the projected $850 million in savings to fund the value-based incentive payments. The 1% reduction will gradually increase each year, topping off at 2 percent by fiscal year 2017 and beyond, meaning that an increasing proportion of hospital payments will be tied to quality measures.

Partnership for Patients Program Launched

The hospital value-based purchasing rule reinforces the goals of another program called the "Partnership for Patients" that was recently launched by the U.S. Department of Health and Human Services ("HHS"). The Partnership for Patients program is a new public-private partnership that is designed to improve the quality, safety and affordability of healthcare. The purpose of the program is to decrease hospital-acquired conditions and prevent complications during a transition from one care setting to another (which would in turn prevent hospital readmissions). HHS believes that the program has the potential over the next three years to save 60,000 lives and save up to $35 billion in U.S. healthcare costs, including up to $10 billion for Medicare.

The program uses up to $1 billion of federal funding that was made available under PPACA. This $1 billion is divided between two initiatives. First, $500 million of the funding will be used by the CMS Innovation Center to support new demonstrations related to reducing hospital-acquired conditions. The initial focus of the Innovation Center will be on nine types of medical errors and complications where the potential for dramatic reductions in harm rates has been demonstrated, including preventing adverse drug reactions, pressure ulcers, childbirth complications and surgical site infections. The Innovation Center will help hospitals adopt evidence-based care improvements to reduce patient injuries and develop approaches to spreading and sharing strategies among public and private partners. The other $500 million of the funding is available through the Community-Based Care Transitions Program, under which community-based organizations and eligible hospitals partner together to help patients safely transition between settings of care. Eligible organizations and hospitals that partner with them can now begin submitting applications for this funding.

In addition, hospitals, employers, health plans, physicians, nurses and state governments can voluntarily "pledge their commitment" to the Partnership for Patients program online. Note that the voluntary pledge is separate from the funding component of the program discussed above. At this point, it is not clear that any specific rights or obligations are associated with making the pledge, other than an aspiration to the program’s quality improvement goals.

An HHS fact sheet announcing the Partnership for Patients program cited a 1999 study by the Institute of Medicine titled "To Err is Human" which estimated that as many as 98,000 Americans die each year from preventable medical errors, and a 2011 study in the Health Affairs journal finding that about one in three patients admitted into a hospital suffer a medical error or adverse event. HHS intends for the Partnerships for Patients program, along with the hospital value-based purchasing rule and other initiatives, to significantly improve quality, reduce adverse outcomes and ultimately reduce U.S. healthcare costs.

If you have any questions about this issue of Health Reform IMPACT, please contact any of the attorneys in our Healthcare Practice Group.


76 Fed. Reg. 26490 (May 6, 2011).
Read "More Bang For The Medicare Buck? CMS Proposes Value-Based Purchasing Program For Hospital Inpatient Services."
3  Pub. L. 111-148 (Mar. 23, 2010), as amended by the Health Care and Education Reconciliation Act of 2010, Pub. L. 111-152 (Mar. 30, 2010). Section 3001(a) of PPACA adds Section 1886(o) to the Social Security Act, which mandates the Program.
The scoring details are set out in detail in the Final Rule.
Additional details about the program can be found on the HHS website.


Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.